Aclaris Therapeutics ACRS
- bosakitug — Atopic Dermatitis Phase 2
- ATI-052 — Atopic Dermatitis Phase 1
- ATI-052 — Asthma Phase 1
- ATI-052 — Eosinophilic Esophagitis
TSLP (3 companies · 10 programs)
Companies with an active program directed at TSLP.
Apogee Therapeutics, Inc. APGE
- APG333 Phase 1
- APG273 — Asthma Preclinical
- APG273 — Chronic Obstructive Pulmonary Disease Preclinical
Celldex Therapeutics, Inc. CLDX
- CDX-622 — Asthma Phase 1
- CDX-622 — Allergic Rhinitis
- CDX-622 — Food Allergy